FDA Inspection 1055818 — James D. Acton, M.D.

James D. Acton, M.D. — FEI 3014378116

The FDA completed an inspection of James D. Acton, M.D. on Jun 15, 2018 in Cincinnati, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 15, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cincinnati, OH (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
722721 CFR 50.27(a)Consent form not approved/signed/dated
756021 CFR 312.60FD-1572, protocol compliance